| Azithromycin |
20010176 |
Sumamed Forte Syrup, Powder for oral suspension, 200 mg/5 ml - 15 ml, -, Pack: 1 |
Екофарм Груп АД, България |
Екофарм ЕООД |
11.38 |
2.28 |
13.66 |
6% |
0.68 |
12.06 |
2.41 |
14.47 |
18% |
2.05 |
14.11 |
2.82 |
16.93 |
КЦPP-1249/15.08.2012 г. |
14.09.2012 |
14.09.2012 |
|
|
Неактивен |
990 |
| Sulfamethoxazole, Trimethoprim |
13521/22.06.2006 г. |
SUMETROLIM, Syrup, 25 mg/ml + 5 mg/ml - 100 ml, -, Pack: 1 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, УНГАРИЯ |
3.31 |
0.66 |
3.97 |
7% |
0.23 |
3.54 |
0.71 |
4.25 |
20% |
0.66 |
4.2 |
0.84 |
5.04 |
КЦ-359/
19,12,2008 г. |
20.01.2009 |
02.09.2020 |
|
|
Активен |
7826 |
| Sulfamethoxazole, Trimethoprim |
13521/22.06.2006 г. |
SUMETROLIM, Syrup, 100 ml, -, Pack: 1 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, УНГАРИЯ |
3.31 |
0.66 |
3.97 |
7% |
0.23 |
3.54 |
0.71 |
4.25 |
20% |
0.66 |
4.2 |
0.84 |
5.04 |
КЦ-359/
19,12,2008 г. |
20.01.2009 |
20.01.2009 |
|
|
Неактивен |
7826 |
| Sulfamethoxazole, Trimethoprim |
II-13432/19.06.2006 г. |
SUMETROLIM, Tablet, 400 mg/80 mg, -, Pack: 20 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, УНГАРИЯ |
2.6 |
0.52 |
3.12 |
7% |
0.18 |
2.78 |
0.56 |
3.34 |
20% |
0.52 |
3.3 |
0.66 |
3.96 |
КЦ-359/
19,12,2008 г. |
20.01.2009 |
02.09.2020 |
|
|
Активен |
7827 |
| Sulfamethoxazole, Trimethoprim |
II-13432/19.06.2006 г. |
SUMETROLIM, Tablet, , -, Pack: 20 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, УНГАРИЯ |
2.6 |
0.52 |
3.12 |
7% |
0.18 |
2.78 |
0.56 |
3.34 |
20% |
0.52 |
3.3 |
0.66 |
3.96 |
КЦ-359/
19,12,2008 г. |
20.01.2009 |
20.01.2009 |
|
|
Неактивен |
7827 |
| Valsartan |
№ II - 10728 / 09.09.2010 |
Suvartar, Film coated tablet, 160 mg, -, Pack: 28 |
Sandoz d.d., Словения |
Salutas Pharma GmbH,Германия, Lek Pharmaceuticals d.d., Lek S.A., |
14.65 |
2.93 |
17.58 |
6% |
0.88 |
15.53 |
3.11 |
18.64 |
18% |
2.64 |
18.17 |
3.63 |
21.8 |
КЦ-2875/06.10.2011 г. |
24.10.2011 |
24.10.2011 |
|
|
Заличен |
3404 |
| Valsartan, Hydrochlorothiazide |
№ II - 10731 / 09.09.2010 |
Suvartar H, Film coated tablet, 160 mg/25 mg, -, Pack: 28 |
Sandoz d.d., Словения |
Salutas Pharma GmbH,Германия, Lek Pharmaceuticals d.d., Lek S.A., |
16.04 |
3.21 |
19.25 |
6% |
0.96 |
17 |
3.4 |
20.4 |
18% |
2.89 |
19.89 |
3.98 |
23.87 |
КЦ-2875/06.10.2011 г. |
24.10.2011 |
24.10.2011 |
|
|
Заличен |
3408 |
| Valsartan, Hydrochlorothiazide |
№ II - 10730 / 09.09.2010 |
Suvartar H, Film coated tablet, 160 mg/12,5 mg, -, Pack: 28 |
Sandoz d.d., Словения |
Salutas Pharma GmbH,Германия, Lek Pharmaceuticals d.d., Lek S.A., |
15.63 |
3.13 |
18.76 |
6% |
0.94 |
16.57 |
3.31 |
19.88 |
18% |
2.81 |
19.38 |
3.88 |
23.26 |
КЦ-2875/06.10.2011 г. |
24.10.2011 |
24.10.2011 |
|
|
Заличен |
3560 |
| Rosuvastatin (as rosuvastatin calcium) |
20100489 |
Suzastor, Film coated tablet, 20 mg, -, Pack: 60 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d.,Словения; Trimlini 2 D, Словения; Lek S.A., Полша; Salutas Pharma GmbH, Германия |
41.66 |
8.33 |
49.99 |
4% |
1.67 |
43.33 |
8.67 |
52 |
16% |
6.67 |
50 |
10 |
60 |
НСР-3336/24.04.2014 |
08.05.2014 |
08.05.2014 |
|
|
Активен |
2251 |
| Rosuvastatin (as rosuvastatin calcium) |
20100488 |
Suzastor, Film coated tablet, 10 mg, -, Pack: 60 |
Sandoz d.d., Словения |
Lek Pharmaceuticals d.d.,Словения; Trimlini 2 D, Словения; Lek S.A., Полша; Salutas Pharma GmbH, Германия |
22.86 |
4.57 |
27.43 |
6% |
1.37 |
24.23 |
4.85 |
29.08 |
18% |
4.11 |
28.34 |
5.67 |
34.01 |
НСР-3335/24.04.2014 |
08.05.2014 |
08.05.2014 |
|
|
Активен |
2250 |
| Ethinyleastradiol, Gestodene |
II-3552/24.11.2008 |
Sylgestrel 20, Coated tablet, 75 mcg/20 mcg, -, Pack: 3 x 21 |
Actavis Group PTC ehf., Исландия |
Haupt Pharma Munster GmbH, Germany |
15.69 |
3.14 |
18.83 |
6% |
0.94 |
16.63 |
3.33 |
19.96 |
18% |
2.82 |
19.45 |
3.89 |
23.34 |
КЦ-550/20.02.2009 г.; НСР-16824/20.09.2018 |
12.03.2009 |
02.11.2018 |
|
|
Заличен |
7941 |
| Ethinyleastradiol, Gestodene |
II-3552/24,11,2008 |
Sylgestrel 20, Coated tablet, 75 mcg/20 mcg, -, Pack: 3 x 21 |
Actavis Group PTC ehf., Исландия |
Haupt Pharma Munster GmbH, Germany |
15.69 |
3.14 |
18.83 |
6% |
0.94 |
16.63 |
3.33 |
19.96 |
18% |
2.82 |
19.45 |
3.89 |
23.34 |
КЦ-550/
20,02,2009 г. |
12.03.2009 |
12.03.2009 |
|
|
Неактивен |
7941 |
| Ethinyleastradiol, Gestodene |
II-3553/24,11,2008 |
Sylgestrel 30, Coated tablet, 75 mcg/30 mcg, -, Pack: 3 x 21 |
Actavis Group PTC ehf., Исландия |
Haupt Pharma Munster GmbH, Germany |
12.62 |
2.52 |
15.14 |
6% |
0.76 |
13.38 |
2.68 |
16.06 |
18% |
2.27 |
15.65 |
3.13 |
18.78 |
КЦ-550/
20,02,2009 г. |
12.03.2009 |
12.03.2009 |
пределната цена е заличена с Решение КЦРР-2612/15.03.2013. |
|
Заличен |
7942 |
| Budesonide, Formoterol |
20010988 |
Symbicort Turbuhaler, Inhalation powder, 160 mcg/ 4,5 mcg/ inhalation, -, Pack: 60 doses |
AstraZeneca AB, Швеция |
AstraZeneca AB, Швеция; AstraZeneca GmbH, Германия; AstraZeneca UK Limited, Великобритания |
38.94 |
7.79 |
46.73 |
4% |
1.56 |
40.5 |
8.1 |
48.6 |
16% |
6.23 |
46.73 |
9.35 |
56.08 |
НСР-8632/31.03.2016 |
15.04.2016 |
15.04.2016 |
|
|
Активен |
9184 |
| Palivizumab |
EU/1/99/117/002 |
Synagis, Powder and solvent for solution for injection, 100, mg, Pack: 1 vial powder + 1 ampoule solvent (1 ml) |
Abbott Laboratories Limited, Обединено Кралство |
Abbot Laboratories S.r.l, Campoverde, Италия |
1592.73 |
318.55 |
1911.28 |
4% |
10 |
1602.73 |
320.55 |
1923.28 |
16% |
25 |
1627.73 |
325.55 |
1953.28 |
КЦ-452/
21,01,2009 г. |
14.02.2009 |
02.09.2020 |
|
|
Активен |
7611 |
| Palivizumab |
EU/1/99/117/002 |
Synagis, powd. inj + solv. Amp., 100 mg + 1ml, -, Pack: 1 |
Abbott Laboratories Limited, Обединено Кралство |
Abbot Laboratories S.r.l, Campoverde, Италия |
1592.73 |
318.55 |
1911.28 |
4% |
10 |
1602.73 |
320.55 |
1923.28 |
16% |
25 |
1627.73 |
325.55 |
1953.28 |
КЦ-452/
21,01,2009 г. |
14.02.2009 |
14.02.2009 |
|
|
Неактивен |
7611 |
| Solutions for parenteral nutrition |
II-13231/ 31.05.2006 |
SYNTHAMIN 14, Solution for infusion, 1000 ml, -, Pack: 1 |
Baxter d.o.o., Словения |
Clintec Parenteral S.A.France/Baxter Helthcare Ltd. UK |
29.83 |
5.97 |
35.8 |
6% |
1.79 |
31.62 |
6.32 |
37.94 |
18% |
5.37 |
36.99 |
7.4 |
44.39 |
КЦ-949/
10,06,2009 г. |
30.06.2009 |
30.06.2009 |
пределната цена е заличена с Решение КЦPP-1393/05.09.2012. |
|
Заличен |
7990 |
| Human Fibrinogen; Human Thrombin |
EU/1/04/277/003 |
TachoSil, medicated sponge, 3 cm x 2,5 cm, -, Pack: |
Takeda Austria GmbH, Австрия |
Takeda Austria GmbH, Austria |
88.01 |
17.6 |
105.61 |
4% |
3.52 |
91.53 |
18.31 |
109.84 |
16% |
14.08 |
105.61 |
21.12 |
126.73 |
КЦ-407/
07,01,2009 г. |
29.01.2009 |
29.01.2009 |
Пределната цена е заличена с Решение НСР-4711/26.09.2014 година, в сила от 10.10.2014 |
|
Заличен |
7945 |
| Human Fibrinogen; Human Thrombin |
EU/1/04/277/001 |
TachoSil, medicated sponge, 9,5 cm x 4,8 cm, -, Pack: |
Takeda Austria GmbH, Австрия |
Takeda Austria GmbH, Austria |
449.84 |
89.97 |
539.81 |
4% |
10 |
459.84 |
91.97 |
551.81 |
16% |
25 |
484.84 |
96.97 |
581.81 |
КЦ-407/
07,01,2009 г. |
29.01.2009 |
29.01.2009 |
Пределната цена е заличена с Решение НСР-4710/26.09.2014 година, в сила от 10.10.2014 |
|
Заличен |
7943 |
| Human Fibrinogen; Human Thrombin |
EU/1/04/277/002 |
TachoSil, medicated sponge, 4,8 cm x 4,8 cm, -, Pack: 2 |
Takeda Austria GmbH, Австрия |
Takeda Austria GmbH, Austria |
488.96 |
97.79 |
586.75 |
4% |
10 |
498.96 |
99.79 |
598.75 |
16% |
25 |
523.96 |
104.79 |
628.75 |
КЦ-407/
07,01,2009 г. |
29.01.2009 |
29.01.2009 |
Пределната цена е заличена с Решение НСР-4712/26.09.2014 година, в сила от 10.10.2014 |
|
Заличен |
7944 |
| Tadalafil |
20180280 |
Tadalacon, Film coated tablet, 20, mg, Pack: 4 |
Фармаконс АД, България |
Фармаконс АД, България |
53 |
10.6 |
63.6 |
4% |
2.12 |
55.12 |
11.02 |
66.14 |
16% |
8.48 |
63.6 |
12.72 |
76.32 |
НСР-18121/07.03.2019 |
22.03.2019 |
02.04.2019 |
|
|
Активен |
16463 |
| Tadalafil |
20170109 |
Tadalafil Accord, Film coated tablet, 20, mg, Pack: 12 |
Accord Healthcare Polska Sp. z.o.o., Полша |
Accord Healthcare Limited, Обединено Кралство; Wessling Hungary Kft, Унгария; Pharmadox Healthcare Ltd, Малта |
75.08 |
15.02 |
90.1 |
4% |
3 |
78.08 |
15.62 |
93.7 |
16% |
12.01 |
90.09 |
18.02 |
108.11 |
НСР-16812/20.09.2018 |
05.10.2018 |
02.10.2019 |
Промяна на обстоятелства НСР-19702/29.08.2019 |
|
Активен |
16284 |
| Tadalafil |
20170109 |
Tadalafil Accord, Film coated tablet, 20, mg, Pack: 12 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено Кралство; Wessling Hungary Kft, Унгария; Pharmadox Healthcare Ltd, Малта |
75.08 |
15.02 |
90.1 |
4% |
3 |
78.08 |
15.62 |
93.7 |
16% |
12.01 |
90.09 |
18.02 |
108.11 |
НСР-16812/20.09.2018 |
05.10.2018 |
02.11.2018 |
|
|
Неактивен |
16284 |
| Tadalafil |
20170109 |
Tadalafil Accord, Film coated tablet, 20, mg, Pack: 4 |
Accord Healthcare Polska Sp. z.o.o., Полша |
Accord Healthcare Limited, Обединено Кралство Wessling Hungary Kft, Унгария, Pharmadox Healthcare Ltd, Малта |
19.36 |
3.87 |
23.23 |
6% |
1.16 |
20.52 |
4.1 |
24.62 |
18% |
3.48 |
24 |
4.8 |
28.8 |
НСР-16595/24.08.2018 |
08.09.2018 |
02.10.2019 |
Промяна на обстоятелства НСР-19702/29.08.2019 |
|
Активен |
16250 |
| Tadalafil |
20170109 |
Tadalafil Accord, Film coated tablet, 20, mg, Pack: 4 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено Кралство Wessling Hungary Kft, Унгария, Pharmadox Healthcare Ltd, Малта |
19.36 |
3.87 |
23.23 |
6% |
1.16 |
20.52 |
4.1 |
24.62 |
18% |
3.48 |
24 |
4.8 |
28.8 |
НСР-16595/24.08.2018 |
08.09.2018 |
02.10.2018 |
|
|
Неактивен |
16250 |